Regulatory · source year
4 selected, source-linked regulatory records dated 2010. This is selective source coverage, not a complete timeline.
4 selected records.
2 connected profiles.
4 distinct public records.
Cited chronology
Tesamorelin
The official Drugs@FDA dataset lists original submission 1 for BLA 022505 with status AP dated 2010-11-10, and names tesamorelin acetate among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Tesamorelin
The Federal Register published notice 2010-6169, attributed to FDA and its parent HHS department, on 2010-03-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.
Source: Federal Register via GovInfo ↗
Liraglutide
The official Drugs@FDA dataset lists original submission 1 for NDA 022341 with status AP dated 2010-01-25, and names liraglutide among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Tesamorelin
The Federal Register published notice 2010-785, attributed to FDA and its parent HHS department, on 2010-01-19. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Tesamorelin.
Source: Federal Register via GovInfo ↗